CIK: 0001839948 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value ($000): $235,414 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| COGT | Cogent Biosciences, Inc. | 3,481,042 | $31,399 | 13.3% | $8.31 | -17.9% | COMMON STOCK | 19240Q201 |
| — | Iveric Bio, Inc. | 2,914,250 | $28,035 | 11.9% | $15.78 | — | COMMON STOCK | 46583P102 |
| GERN | Geron Corporation | 15,096,342 | $23,399 | 9.9% | $1.13 | +24.9% | COMMON STOCK | 374163103 |
| KURA | Kura Oncology, Inc. | 1,167,642 | $21,403 | 9.1% | $14.41 | -0.2% | COMMON STOCK | 50127T109 |
| — | CymaBay Therapeutics, Inc. | 5,905,400 | $17,421 | 7.4% | $3.38 | — | COMMON STOCK | 23257D103 |
| ACRS | Aclaris Therapeuitics, Inc. | 1,144,939 | $15,983 | 6.8% | $15.07 | -7.0% | COMMON STOCK | 00461U105 |
| VRDN | Viridian Therapeutics Inc | 1,314,000 | $15,203 | 6.5% | $18.63 | -27.9% | COMMON STOCK | 92790C104 |
| — | Chinook Therapeutics, Inc. | 796,460 | $13,930 | 5.9% | $16.31 | — | COMMON STOCK | 16961L106 |
| — | Aerovate Therapeutics, Inc. | 889,572 | $13,904 | 5.9% | $12.06 | — | COMMON STOCK | 008064107 |
| TRDA | Entrada Therapeutics, Inc. | 663,694 | $8,084 | 3.4% | $17.12 | — | COMMON STOCK | 29384C108 |
| — | Merus N.V. | 300,000 | $6,792 | 2.9% | $30.46 | — | COMMON STOCK | N5749R100 |
| TYRA | Tyra Biosciences, Inc. | 896,418 | $6,409 | 2.7% | $19.46 | -59.1% | COMMON STOCK | 90240B106 |
| — | Akouos, Inc. | 1,350,006 | $6,332 | 2.7% | $7.65 | — | COMMON STOCK | 00973J101 |
| TNGX | Tango Therapeutics, Inc. | 1,172,250 | $5,310 | 2.3% | $8.67 | -30.1% | COMMON STOCK | 87583X109 |
| MLTX | MoonLake Immunotherapeutics | 1,000,000 | $5,250 | 2.2% | $6.29 | 0.0% | COMMON STOCK | 61559X104 |
| — | Alpine Immune Sciences, Inc. | 578,260 | $4,921 | 2.1% | $13.85 | — | COMMON STOCK | 02083G100 |
| — | 89bio, Inc. | 1,133,196 | $3,649 | 1.6% | $3.22 | — | COMMON STOCK | 282559103 |
| ZLAB | Zai Lab LTD-ADR | 95,000 | $3,295 | 1.4% | $62.85 | — | COMMON STOCK | 98887Q104 |
| — | Magenta Therapeutics, Inc. | 2,124,122 | $2,549 | 1.1% | $4.43 | — | COMMON STOCK | 55910K108 |
| ANAB | AnaptysBio, Inc. | 58,515 | $1,188 | 0.5% | $30.26 | -26.8% | COMMON STOCK | 032724106 |
| — | Elevation Oncology, Inc. | 555,000 | $777 | 0.3% | $6.02 | — | COMMON STOCK | 28623U101 |
| — | Pardes Biosciences, Inc. | 59,039 | $181 | 0.1% | $7.22 | — | COMMON STOCK | 69945Q105 |